Billion-Dollar Molecules: Voxelotor, A $5.4 Billion Reversible Covalent Aldehyde | https://t.co/FEScFDVcyu Pfizer expands its presence in genetic diseases by acquiring voxelotor from Global Blood Therapeutics. Dive into the mechanism of action of the first-in-class drug and more https://t.co/vP7g4dTb5C
No comments:
Post a Comment